Literature DB >> 11587220

Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues.

R J McNally1, D P Cairns, O B Eden, A M Kelsey, G M Taylor, J M Birch.   

Abstract

The age-sex distributions and temporal trends in incidence of leukaemia and lymphoma from the Manchester Children's Tumour Registry (MCTR), 1954-1998, are reported. This 45-year study includes 1795 children, all of whom had a histologically and/or cytologically verified leukaemia or lymphoma. At the time of their diagnoses all the children were under 15 years of age and were resident in a geographically defined area of northwest England covered by the MCTR. Log-linear modelling identified significant linear increases in acute lymphoblastic leukaemia (ALL) (average annual increase 0.7%; P= 0.005) and in Hodgkin's disease (HD) (1.2%, P=0.04), but not in acute myeloid leukaemia (AML), nor in non-Hodgkin's lymphoma (NHL). The increase in ALL was most pronounced amongst males, aged 1-4 years, and is likely to be due to precursor B-cell leukaemias. The increases in ALL and HD are discussed in relation to current hypotheses suggesting a role for infection. Additionally, a non-linear cohort effect was identified for NHL (P= 0.008), which may indicate the involvement of environmental factors other than infection.

Entities:  

Mesh:

Year:  2001        PMID: 11587220     DOI: 10.1038/sj.leu.2402252

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  11 in total

1.  Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study.

Authors:  Casey Crump; Kristina Sundquist; Weiva Sieh; Marilyn A Winkleby; Jan Sundquist
Journal:  J Natl Cancer Inst       Date:  2012-05-22       Impact factor: 13.506

2.  A web tool for age-period-cohort analysis of cancer incidence and mortality rates.

Authors:  Philip S Rosenberg; David P Check; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-21       Impact factor: 4.254

3.  Age-period-cohort models in cancer surveillance research: ready for prime time?

Authors:  Philip S Rosenberg; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

4.  Proportional hazards models and age-period-cohort analysis of cancer rates.

Authors:  Philip S Rosenberg; William F Anderson
Journal:  Stat Med       Date:  2010-05-20       Impact factor: 2.373

5.  Are incidence rates of adult leukemia in the United States significantly associated with birth cohort?

Authors:  Philip S Rosenberg; Katherine L Wilson; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-12       Impact factor: 4.254

6.  Age-period-cohort modelling of non-Hodgkin's lymphoma incidence in a French region: a period effect compatible with an environmental exposure.

Authors:  Jean-François Viel; Evelyne Fournier; Arlette Danzon
Journal:  Environ Health       Date:  2010-08-08       Impact factor: 5.984

7.  Effects of changes in diagnosis and registration on time trends in recorded childhood cancer incidence in Great Britain.

Authors:  M E Kroll; L M Carpenter; M F G Murphy; C A Stiller
Journal:  Br J Cancer       Date:  2012-08-16       Impact factor: 7.640

8.  Classification and incidence of cancers in adolescents and young adults in England 1979-1997.

Authors:  J M Birch; R D Alston; A M Kelsey; M J Quinn; P Babb; R J Q McNally
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

9.  Childhood cancer incidence in British Indians & Whites in Leicester, 1996-2008.

Authors:  Shameq Sayeed; Isobel Barnes; Benjamin J Cairns; Alexander Finlayson; Raghib Ali
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

10.  Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the Cancer registry (a population-based study).

Authors:  Arturo Fajardo-Gutiérrez; Servando Juárez-Ocaña; Guadalupe González-Miranda; Virginia Palma-Padilla; Rogelio Carreón-Cruz; Manuel Carlos Ortega-Alvárez; Juan Manuel Mejía-Arangure
Journal:  BMC Cancer       Date:  2007-04-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.